{"title":"All Research Peptides","description":"\u003cp\u003eOur full range of research-grade peptides, sold strictly for in vitro laboratory use. All products are manufactured to ≥99% purity and are not intended for human consumption.\u003c\/p\u003e","products":[{"product_id":"bpc-157","title":"BPC 157","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eBPC-157\u003c\/strong\u003e (Body Protection Compound-157; sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) is a synthetic pentadecapeptide derived from a body protection compound found in human gastric juice. It is one of the most extensively studied regenerative peptides in preclinical science, investigated for its roles in angiogenesis, tendon-to-bone healing, skeletal muscle regeneration, and gastrointestinal mucosal protection.\u003c\/p\u003e\u003cp\u003eBPC-157 has been shown in preclinical models to modulate VEGF, EGF, and nitric oxide signalling pathways, while also influencing dopaminergic and serotonergic neurotransmission. Its exceptional stability in human gastric juice and broad preclinical activity profile make it one of the most studied compounds in regenerative and GI research.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e 137525-51-0  ·  \u003cstrong\u003eFormula:\u003c\/strong\u003e C62H98N16O22  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e 1419.5 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e Tissue regeneration · Angiogenesis · GI mucosal biology · Tendon \u0026amp; ligament repair · Wound healing · Nitric oxide signalling · Neurological models\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSelected Research Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25995620\/\" target=\"_blank\" rel=\"noopener\"\u003eAlkali-burn wound healing and angiogenesis in vivo (PMID 25995620)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32334036\/\" target=\"_blank\" rel=\"noopener\"\u003ePreclinical safety evaluation of BPC-157 (PMID 32334036)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40005999\/\" target=\"_blank\" rel=\"noopener\"\u003eMultifunctionality and medical application review (PMID 40005999)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=BPC-157+pentadecapeptide+tissue\" target=\"_blank\" rel=\"noopener\"\u003eFull PubMed literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"5mg","offer_id":53108990312781,"sku":null,"price":25.0,"currency_code":"GBP","in_stock":true},{"title":"10mg","offer_id":53108990345549,"sku":null,"price":40.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/BPC1575mgBox-M.jpg?v=1770811988"},{"product_id":"selank","title":"Selank","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSelank\u003c\/strong\u003e (sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic heptapeptide analogue of the endogenous immunomodulatory peptide tuftsin, developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It is studied for its role in GABA-A receptor modulation, serotonergic and dopaminergic signalling, and anxiolytic-like mechanisms in laboratory research models.\u003c\/p\u003e\u003cp\u003eSelank exhibits improved metabolic stability over endogenous tuftsin, with preclinical research exploring its interaction with multiple neurotransmitter systems. It is commonly used in laboratory investigations of stress response, memory consolidation, and neurological resilience pathways, including work on cytokine profiles and neuroimmune signalling.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e 129954-34-3  ·  \u003cstrong\u003eFormula:\u003c\/strong\u003e C33H57N11O9  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e 751.9 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e Anxiolytic mechanisms · GABA-A modulation · Memory \u0026amp; cognitive function · Serotonergic signalling · Stress response · Neuroimmunology\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=selank+tuftsin+neuropeptide+anxiety\" target=\"_blank\" rel=\"noopener\"\u003ePubMed: Selank research literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"5mg","offer_id":53108974649677,"sku":null,"price":22.5,"currency_code":"GBP","in_stock":true},{"title":"10mg","offer_id":53108974682445,"sku":null,"price":40.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/SELANK10mgBox-M.jpg?v=1770812647"},{"product_id":"semax","title":"Semax","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSemax\u003c\/strong\u003e (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic heptapeptide analogue of the ACTH(4-7) fragment, with a C-terminal Pro-Gly-Pro extension that confers improved metabolic stability over the parent peptide. Developed originally in Russia, it is widely studied for its role in BDNF (brain-derived neurotrophic factor) upregulation, neuroprotective signalling, and modulation of the hypothalamic-pituitary-adrenal (HPA) axis.\u003c\/p\u003e\u003cp\u003ePreclinical research has investigated Semax in stroke models, ischaemia-reperfusion studies, cognitive function, and memory consolidation pathways. Its ACTH-derived structure enables interaction with melanocortin receptors (MC2R\/MC4R), while the Pro-Gly-Pro extension increases peptidase resistance versus the parent ACTH(4-7) fragment.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e 80714-61-0  ·  \u003cstrong\u003eFormula:\u003c\/strong\u003e C37H51N9O10S  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e 813.9 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e BDNF upregulation · Neuroprotection · Cognitive \u0026amp; memory function · ACTH-receptor pharmacology · HPA axis modulation · Stroke \u0026amp; ischaemia models\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=semax+ACTH+BDNF+neuropeptide+cognition\" target=\"_blank\" rel=\"noopener\"\u003ePubMed: Semax research literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"5mg","offer_id":53108991557965,"sku":null,"price":20.0,"currency_code":"GBP","in_stock":false},{"title":"10mg","offer_id":53108991590733,"sku":null,"price":38.0,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/SEMAX10mgBox-M.jpg?v=1770812607"},{"product_id":"dsip","title":"DSIP","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eDSIP (Delta Sleep-Inducing Peptide)\u003c\/strong\u003e (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) is a neuromodulatory nonapeptide first isolated from rabbit cerebral venous blood in 1974. It is studied for its role in circadian rhythm regulation, stress hormone modulation, and neurophysiological signalling related to sleep-wake cycles in preclinical research models.\u003c\/p\u003e\u003cp\u003eDSIP has been explored for its ability to modulate ACTH, cortisol, and somatostatin release, its interaction with opiate receptor systems, and its putative role in normalising sleep architecture in animal models of disrupted circadian function. Its broad neuromodulatory profile makes it a useful research tool in sleep biology, neuroendocrinology, and stress physiology.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e 62568-57-4  ·  \u003cstrong\u003eFormula:\u003c\/strong\u003e C35H48N10O15  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e 848.8 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e Circadian rhythm · Delta wave sleep regulation · ACTH \u0026amp; cortisol modulation · Somatostatin interaction · Neuroendocrinology · Opiate receptor research\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=DSIP+delta+sleep-inducing+peptide+circadian+neuroendocrine\" target=\"_blank\" rel=\"noopener\"\u003ePubMed: DSIP research literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"5mg","offer_id":53108994867533,"sku":null,"price":20.0,"currency_code":"GBP","in_stock":true},{"title":"15mg","offer_id":53108994900301,"sku":null,"price":50.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/DSIP5mgBox-M.jpg?v=1770812569"},{"product_id":"ss31","title":"SS-31","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSS-31 (Elamipretide)\u003c\/strong\u003e (D-Arg-2'6'-dimethylTyr-Lys-Phe-NH₂) is a mitochondria-targeting synthetic tetrapeptide with a unique alternating cationic-aromatic sequence that enables rapid, energy-independent accumulation at the inner mitochondrial membrane. It is studied for its role in cardiolipin stabilisation, reactive oxygen species (ROS) reduction, and restoration of mitochondrial cristae architecture.\u003c\/p\u003e\u003cp\u003ePreclinical and early clinical research has investigated SS-31 across multiple models of mitochondrial dysfunction, including cardiac ischaemia-reperfusion injury, age-related mitochondrial decline, acute kidney injury, and neurodegenerative disease models. Its mechanism centres on cardiolipin interaction, which restores electron transport chain efficiency and reduces oxidative stress without altering mitochondrial membrane potential.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e 736992-21-5  ·  \u003cstrong\u003eSequence:\u003c\/strong\u003e D-Arg-dmTyr-Lys-Phe-NH₂  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e ~639.8 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e Cardiolipin stabilisation · Mitochondrial bioenergetics · ROS reduction · Cardiac ischaemia models · Renal protection · Age-related mitochondrial decline\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28487636\/\" target=\"_blank\" rel=\"noopener\"\u003eSS-31 ameliorates isoflurane-induced mitochondrial impairment (PMID 28487636)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=elamipretide+SS-31+mitochondria+cardiolipin\" target=\"_blank\" rel=\"noopener\"\u003ePubMed: SS-31 \/ Elamipretide research literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"10mg","offer_id":53108999881037,"sku":null,"price":39.0,"currency_code":"GBP","in_stock":true},{"title":"50mg","offer_id":53108999913805,"sku":null,"price":70.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/SS3110mgBox-M.jpg?v=1770812534"},{"product_id":"klow","title":"Klow Blend","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eKLOW Blend\u003c\/strong\u003e is a four-component research peptide combination formulated for laboratory studies focused on tissue repair, immune modulation, and cellular regeneration. The blend comprises: \u003cstrong\u003eGHK-Cu\u003c\/strong\u003e (CAS 49557-75-7) — copper tripeptide studied for ECM remodelling and collagen synthesis; \u003cstrong\u003eTB-500\u003c\/strong\u003e — actin-sequestering Thymosin β4 fragment (parent CAS 107761-42-2) studied for cellular migration and angiogenesis; \u003cstrong\u003eBPC-157\u003c\/strong\u003e (CAS 137525-51-0) — gastric pentadecapeptide studied for tissue regeneration and GI mucosal protection; and \u003cstrong\u003eKPV\u003c\/strong\u003e — alpha-MSH C-terminal tripeptide studied for MC1R-mediated anti-inflammatory signalling.\u003c\/p\u003e\u003cp\u003eThe combination targets complementary repair and regeneration pathways: angiogenic (TB-500\/BPC-157), matrix remodelling (GHK-Cu), and immunomodulatory (KPV), making KLOW Blend useful in multi-target preclinical research on skin biology, wound healing, and inflammatory tissue response.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eComponents:\u003c\/strong\u003e GHK-Cu · TB-500 · BPC-157 · KPV  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC (each component)  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder blend  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e Multi-target tissue repair · ECM remodelling · Wound healing · Anti-inflammatory signalling · Angiogenesis · Cellular migration · Skin biology\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25995620\/\" target=\"_blank\" rel=\"noopener\"\u003eBPC-157: wound healing and angiogenesis in vivo (PMID 25995620)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35083444\/\" target=\"_blank\" rel=\"noopener\"\u003eGHK-Cu as anti-aging peptide (PMID 35083444)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10469335\/\" target=\"_blank\" rel=\"noopener\"\u003eThymosin beta4 accelerates wound healing (PMID 10469335)\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"80mg","offer_id":53109161394509,"sku":null,"price":90.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/KLOW80mgBox-M.jpg?v=1770812498"},{"product_id":"glow","title":"Glow Blend","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eGLOW Blend\u003c\/strong\u003e is a three-component research peptide combination designed for laboratory studies on skin ECM remodelling, wound healing, and regenerative signalling. The blend contains: \u003cstrong\u003eGHK-Cu\u003c\/strong\u003e (CAS 49557-75-7) — copper tripeptide studied for collagen synthesis, glycosaminoglycan turnover, and antioxidant signalling; \u003cstrong\u003eTB-500\u003c\/strong\u003e — the LKKTETQ actin-binding fragment of Thymosin β4 (parent CAS 107761-42-2) studied for cell migration and angiogenesis; and \u003cstrong\u003eBPC-157\u003c\/strong\u003e (CAS 137525-51-0) — gastric-derived pentadecapeptide studied for tissue repair, VEGF signalling, and NO pathway modulation.\u003c\/p\u003e\u003cp\u003eTogether, these three compounds address three distinct but complementary aspects of skin repair biology: matrix synthesis and remodelling (GHK-Cu), vascular and cellular recruitment (TB-500), and growth factor signalling and mucosal integrity (BPC-157).\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eComponents:\u003c\/strong\u003e GHK-Cu · TB-500 · BPC-157  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC (each component)  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder blend  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e Skin ECM remodelling · Collagen synthesis · Wound healing · Angiogenesis · VEGF \/ NO signalling · Regenerative biology\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26236730\/\" target=\"_blank\" rel=\"noopener\"\u003eGHK as modulator of skin regeneration pathways (PMID 26236730)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/14500546\/\" target=\"_blank\" rel=\"noopener\"\u003eActin binding site of thymosin beta4 promotes angiogenesis (PMID 14500546)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40005999\/\" target=\"_blank\" rel=\"noopener\"\u003eBPC-157: multifunctionality review (PMID 40005999)\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"70mg","offer_id":53109160477005,"sku":null,"price":75.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/GLOW70mgBox-M.jpg?v=1770812462"},{"product_id":"ghk-cu","title":"GHK-CU","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eGHK-Cu (Copper Tripeptide-1)\u003c\/strong\u003e (Gly-His-Lys·Cu²⁺; CAS 49557-75-7) is a naturally occurring copper peptide complex found in human plasma, saliva, and urine. Serum concentrations decline from approximately 200 ng\/mL at age 20 to 80 ng\/mL by age 60, making it a subject of significant interest in aging biology. GHK-Cu is extensively studied for its role in extracellular matrix remodelling, collagen and glycosaminoglycan synthesis, wound healing, and skin regeneration.\u003c\/p\u003e\u003cp\u003eResearch has demonstrated that GHK-Cu activates a broad programme of skin remodelling genes, stimulates both synthesis and regulated breakdown of collagen via metalloproteinase modulation, and promotes wound healing across multiple tissue types including skin, hair follicles, gastrointestinal tract, and bone. Its antioxidant and anti-inflammatory properties have been documented in numerous in vitro and in vivo studies.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e 49557-75-7  ·  \u003cstrong\u003eFormula:\u003c\/strong\u003e C14H24CuN6O4  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e 403.9 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e Collagen synthesis \u0026amp; ECM remodelling · Wound healing · Skin regeneration · Anti-inflammatory signalling · Hair follicle biology · Angiogenesis · Anti-aging research\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSelected Research Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35083444\/\" target=\"_blank\" rel=\"noopener\"\u003eGHK as an anti-aging peptide: mechanisms and potential (PMID 35083444)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26236730\/\" target=\"_blank\" rel=\"noopener\"\u003eGHK as modulator of multiple cellular pathways in skin regeneration (PMID 26236730)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23019153\/\" target=\"_blank\" rel=\"noopener\"\u003eStem cell recovering effect of copper-free GHK in skin (PMID 23019153)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=GHK-Cu+copper+tripeptide+wound+healing+collagen\" target=\"_blank\" rel=\"noopener\"\u003eFull PubMed literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"50mg \/ Standard","offer_id":53109106344269,"sku":null,"price":35.0,"currency_code":"GBP","in_stock":true},{"title":"50mg \/ C","offer_id":54254540816717,"sku":null,"price":38.0,"currency_code":"GBP","in_stock":true},{"title":"50mg \/ K","offer_id":54254540849485,"sku":null,"price":55.0,"currency_code":"GBP","in_stock":true},{"title":"100mg \/ Standard","offer_id":53109106377037,"sku":null,"price":60.0,"currency_code":"GBP","in_stock":true},{"title":"100mg \/ C","offer_id":54254540882253,"sku":null,"price":63.0,"currency_code":"GBP","in_stock":false},{"title":"100mg \/ K","offer_id":54254540915021,"sku":null,"price":80.0,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/GHK-CU50mgBox-M.jpg?v=1770812423"},{"product_id":"bpc157-tb500","title":"BPC157 + TB500","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eBPC-157 + TB-500\u003c\/strong\u003e is a research peptide combination pairing two of the most studied tissue-repair compounds in preclinical science. BPC-157 (CAS 137525-51-0) is a gastric-derived pentadecapeptide studied for angiogenesis, GI mucosal protection, and musculoskeletal healing. TB-500 (the active actin-sequestering fragment of Thymosin β4; parent compound CAS 107761-42-2) is studied for cellular migration, connective tissue repair, and cardiac regeneration pathways.\u003c\/p\u003e\u003cp\u003eThe combination is frequently investigated in preclinical recovery research due to their complementary and potentially synergistic mechanisms: BPC-157 primarily through NO-system modulation and growth factor signalling, and TB-500 through actin sequestration and LKKTETQ-domain-mediated cell migration. Available in 10 mg and 20 mg formats.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eBPC-157 CAS:\u003c\/strong\u003e 137525-51-0  ·  \u003cstrong\u003eTB-500 (Thymosin β4) CAS:\u003c\/strong\u003e 107761-42-2  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC (each component)  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder blend  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e Synergistic tissue repair · Angiogenesis · Musculoskeletal recovery · GI mucosal biology · Cardiac regeneration models · Cellular migration\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25995620\/\" target=\"_blank\" rel=\"noopener\"\u003eBPC-157: wound healing and angiogenesis in vivo (PMID 25995620)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10469335\/\" target=\"_blank\" rel=\"noopener\"\u003eThymosin beta4 accelerates wound healing (PMID 10469335)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/14500546\/\" target=\"_blank\" rel=\"noopener\"\u003eActin binding site of thymosin beta4 promotes angiogenesis (PMID 14500546)\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"10mg","offer_id":53109160018253,"sku":null,"price":50.0,"currency_code":"GBP","in_stock":false},{"title":"20mg","offer_id":53425628479821,"sku":null,"price":80.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/BPC1575mgBox-M_a4d627c9-c3f6-4529-a4d8-a3e857df1e4d.jpg?v=1770812387"},{"product_id":"mots-c","title":"MOTS-C","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eMOTS-c (Mitochondrial Open Reading Frame of 12S rRNA-c)\u003c\/strong\u003e is a 16-amino-acid mitochondria-derived peptide (MDP) encoded by a short open reading frame within the mitochondrial 12S rRNA gene. Discovered by Lee et al. in 2015, it represents a novel class of mitochondria-encoded hormones. MOTS-c is studied for its role in metabolic homeostasis, AMPK activation, insulin sensitivity, and adaptation to cellular stress.\u003c\/p\u003e\u003cp\u003eResearch has established MOTS-c as primarily acting on skeletal muscle, where it inhibits the folate cycle and de novo purine biosynthesis, leading to AMPK activation and improved metabolic signalling. In murine studies, MOTS-c treatment prevented age-dependent and high-fat-diet-induced insulin resistance and diet-induced obesity, positioning it as a key research target in metabolic disease, aging, and exercise biology.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003ePubChem CID:\u003c\/strong\u003e 176489569  ·  \u003cstrong\u003eFormula:\u003c\/strong\u003e C101H152N28O22S2  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e ~2,147 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e Metabolic homeostasis · AMPK activation · Insulin sensitivity · Obesity models · Mitochondrial biology · Exercise physiology · Aging research\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSelected Research Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25738459\/\" target=\"_blank\" rel=\"noopener\"\u003eMOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance (PMID 25738459)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27216708\/\" target=\"_blank\" rel=\"noopener\"\u003eMOTS-c: a novel MDP regulating muscle and fat metabolism (PMID 27216708)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=MOTS-c+mitochondrial+derived+peptide+metabolism\" target=\"_blank\" rel=\"noopener\"\u003eFull PubMed literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"10mg","offer_id":53109143732557,"sku":null,"price":29.0,"currency_code":"GBP","in_stock":false},{"title":"40mg","offer_id":53109143765325,"sku":null,"price":58.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/MOTS-C40mgBox-M.jpg?v=1770812311"},{"product_id":"mt1","title":"MT1","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eMT-1 (Melanotan-1 \/ Afamelanotide)\u003c\/strong\u003e is a synthetic linear analogue of alpha-melanocyte stimulating hormone (α-MSH), differing from the native peptide by a single amino acid substitution (norleucine for methionine at position 4) which confers enhanced receptor binding affinity and metabolic stability. It acts as a potent MC1R agonist and is studied for its roles in melanogenesis, UV-response pathways, and photoprotection biology.\u003c\/p\u003e\u003cp\u003eMT-1 has been the subject of both preclinical and clinical research. The EMA-approved form (afamelanotide) is used clinically for erythropoietic protoporphyria — making this one of the few melanocortin research peptides with a regulatory approval precedent. Preclinical research explores MC1R-mediated signalling, pigmentation pathways, immune modulation, and inflammatory response.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e 75921-69-6  ·  \u003cstrong\u003eFormula:\u003c\/strong\u003e C78H111N21O19  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e 1646.9 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e MC1R pharmacology · Melanogenesis · UV photoprotection · Erythropoietic protoporphyria models · Immune modulation · Anti-inflammatory signalling\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=afamelanotide+melanotan-1+MC1R+melanocortin\" target=\"_blank\" rel=\"noopener\"\u003ePubMed: Melanotan-1 \/ Afamelanotide research literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"10mg","offer_id":53109159395661,"sku":null,"price":25.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/MT-110mg-M.jpg?v=1776331799"},{"product_id":"aod-9604","title":"AOD 9604","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eAOD-9604\u003c\/strong\u003e is a synthetic peptide fragment corresponding to residues 177–191 of human growth hormone (hGH), with a tyrosine modification at the N-terminus. Unlike full-length hGH, AOD-9604 does not bind the IGF-1 receptor or stimulate IGF-1 production, making it a selective tool for studying fat metabolism pathways without the anabolic effects associated with hGH.\u003c\/p\u003e\u003cp\u003ePreclinical research has investigated AOD-9604 for its ability to stimulate lipolysis and inhibit lipogenesis in adipocyte models, with studies exploring β3-adrenergic receptor involvement. It has undergone Phase I–III clinical trials for metabolic disorders, providing a substantial safety and pharmacokinetic dataset useful for research context.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e 221231-10-3  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e ~1817 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e Lipolysis · Lipogenesis inhibition · Fat metabolism · β3-adrenergic signalling · hGH fragment pharmacology · Metabolic disease models\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=AOD-9604+growth+hormone+fragment+lipolysis+fat+metabolism\" target=\"_blank\" rel=\"noopener\"\u003ePubMed: AOD-9604 research literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"5mg","offer_id":53109156774221,"sku":null,"price":38.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/AOD96045mgBox-M.jpg?v=1770812277"},{"product_id":"cjc-1295-no-dac","title":"CJC 1295 NO DAC IPAMORELIN","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eCJC-1295 (No DAC) + Ipamorelin\u003c\/strong\u003e is a research peptide combination pairing a GHRH analogue with a selective GHRP to produce synergistic growth hormone secretagogue activity. CJC-1295 (No DAC; CAS 863288-34-0) is a 30-amino-acid GHRH analogue studied for its ability to stimulate pulsatile GH release from pituitary somatotrophs without drug affinity complex (DAC) extension. Ipamorelin (CAS 170851-70-4) is a highly selective pentapeptide GHRP that acts on the ghrelin\/GHS-R1a receptor to potentiate GH secretion with minimal off-target effects on cortisol or prolactin.\u003c\/p\u003e\u003cp\u003eThe combination is studied in preclinical endocrinology research for its ability to model pulsatile GH physiology, investigate somatotroph function, and study downstream IGF-1 and metabolic signalling. The two compounds act via distinct but complementary receptor pathways (GHRH-R and GHS-R1a), making their combination a useful dual-agonist research tool.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCJC-1295 CAS:\u003c\/strong\u003e 863288-34-0  ·  \u003cstrong\u003eIpamorelin CAS:\u003c\/strong\u003e 170851-70-4  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC (each component)  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder blend  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e Pulsatile GH release · GHRH-R \/ GHS-R1a dual agonism · Endocrine signalling · IGF-1 pathway · Pituitary somatotroph function · Metabolic research\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9849822\/\" target=\"_blank\" rel=\"noopener\"\u003eIpamorelin: first selective growth hormone secretagogue (PMID 9849822)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10496658\/\" target=\"_blank\" rel=\"noopener\"\u003ePK\/PD modelling of ipamorelin in human volunteers (PMID 10496658)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=CJC-1295+ipamorelin+growth+hormone+GHRH\" target=\"_blank\" rel=\"noopener\"\u003ePubMed: CJC-1295 + Ipamorelin research literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"10mg","offer_id":53109168570701,"sku":null,"price":45.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/CJC-1295NODA10mgBox-M.jpg?v=1770812241"},{"product_id":"tb-500","title":"TB-500 (889)","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eTB-500 (889)\u003c\/strong\u003e is a synthetic version of the actin-sequestering active region of Thymosin β4, corresponding to the LKKTETQ heptapeptide motif (amino acids 17–23 of full-length Thymosin β4; parent protein CAS 107761-42-2). The 889 designation refers to the specific fragment studied extensively for its role in cellular migration, angiogenesis, and tissue-response pathways.\u003c\/p\u003e\u003cp\u003eResearch has established that the LKKTETQ actin-binding domain is primarily responsible for the wound-healing and angiogenic activity observed with full-length Thymosin β4. TB-500 sequesters G-actin, reducing the intracellular G\/F-actin ratio and thereby promoting cell motility, blood vessel formation, and matrix remodelling. Studies have documented activity in cardiac regeneration, skin wound healing, and musculoskeletal repair models.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eParent Compound CAS:\u003c\/strong\u003e 107761-42-2 (Thymosin β4)  ·  \u003cstrong\u003eActive Fragment:\u003c\/strong\u003e Ac-LKKTETQ-OH  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e Actin sequestration · Cellular migration · Wound healing · Angiogenesis · Cardiac repair models · Connective tissue repair\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSelected Research Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10469335\/\" target=\"_blank\" rel=\"noopener\"\u003eThymosin beta4 accelerates wound healing (PMID 10469335)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/14500546\/\" target=\"_blank\" rel=\"noopener\"\u003eActin binding site of thymosin beta4 promotes angiogenesis (PMID 14500546)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38382158\/\" target=\"_blank\" rel=\"noopener\"\u003eTB-500 metabolites and wound healing activity in vitro (PMID 38382158)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=thymosin+beta-4+TB-500+wound+healing+actin\" target=\"_blank\" rel=\"noopener\"\u003eFull PubMed literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"5mg","offer_id":53109181382989,"sku":null,"price":25.0,"currency_code":"GBP","in_stock":true},{"title":"10mg","offer_id":53109181415757,"sku":null,"price":50.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/TB50010mgBox-M.jpg?v=1770812200"},{"product_id":"tesamorelin","title":"Tesamorelin","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eTesamorelin\u003c\/strong\u003e is a synthetic analogue of endogenous growth hormone-releasing hormone (GHRH), comprising the full 44-amino acid sequence of GHRH with a trans-3-hexenoic acid moiety conjugated to the N-terminus for enhanced metabolic stability. This modification extends its plasma half-life relative to native GHRH while preserving high-affinity binding to the GHRH receptor (GHRH-R).\u003c\/p\u003e\u003cp\u003eTesamorelin is a clinically validated compound (FDA-approved as Egrifta for HIV-associated lipodystrophy), providing an extensive pharmacological and pharmacokinetic dataset for research context. Preclinical research examines its role in pulsatile GH secretion, IGF-1 pathway modulation, lipid metabolism, and neuroendocrine function. Its high receptor selectivity makes it a valuable tool for GHRH-R pathway investigation.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e 218949-48-5  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e ~5135.9 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e GHRH-R pharmacology · Pulsatile GH secretion · IGF-1 signalling · Lipid metabolism · Lipodystrophy models · Neuroendocrine function\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=tesamorelin+GHRH+growth+hormone+lipodystrophy\" target=\"_blank\" rel=\"noopener\"\u003ePubMed: Tesamorelin research literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"5mg","offer_id":53109185642829,"sku":null,"price":35.0,"currency_code":"GBP","in_stock":true},{"title":"8.88mg","offer_id":54162039734605,"sku":null,"price":47.5,"currency_code":"GBP","in_stock":true},{"title":"10mg","offer_id":53109185675597,"sku":null,"price":65.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/Tesamorelin5mgBox-M.jpg?v=1770812162"},{"product_id":"5-amino-1mq","title":"5-Amino 1MQ","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003e5-Amino-1MQ\u003c\/strong\u003e (5-amino-1-methylquinolinium iodide; CAS 42464-96-0) is a selective, cell-permeable inhibitor of nicotinamide N-methyltransferase (NNMT) — an enzyme that methylates nicotinamide (vitamin B3) to produce 1-methylnicotinamide, thereby consuming SAM (S-adenosylmethionine) and depleting methyl group availability for epigenetic and metabolic processes. NNMT is highly expressed in adipose tissue, where its activity correlates with obesity, insulin resistance, and metabolic syndrome.\u003c\/p\u003e\u003cp\u003eBy inhibiting NNMT, 5-Amino-1MQ increases intracellular NAD⁺ precursor availability, restores methyl group balance, and has been shown in preclinical models to reduce adiposity and improve insulin sensitivity. It is studied as a research tool for NNMT biology, one-carbon metabolism, NAD⁺\/NADH homeostasis, and epigenetic methylation dynamics in metabolic disease models.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e 42464-96-0  ·  \u003cstrong\u003eFormula:\u003c\/strong\u003e C10H11IN2 (iodide salt)  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e 286.1 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥98% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C, protected from light\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e NNMT inhibition · NAD⁺ metabolism · One-carbon metabolism · Epigenetic methylation · Adipogenesis · Metabolic disease models · SAM\/SAH ratio\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=5-amino-1MQ+NNMT+inhibitor+NAD+metabolism\" target=\"_blank\" rel=\"noopener\"\u003ePubMed: 5-Amino-1MQ research literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"5mg","offer_id":53109196587341,"sku":null,"price":21.0,"currency_code":"GBP","in_stock":false},{"title":"50mg","offer_id":53128323531085,"sku":null,"price":68.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/5AMINO1MQ5mgBox-M.jpg?v=1770812125"},{"product_id":"nad","title":"NAD+","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eNAD⁺ (Nicotinamide Adenine Dinucleotide)\u003c\/strong\u003e (CAS 53-84-9) is a fundamental coenzyme present in all living cells, functioning as an electron carrier in redox reactions and as a substrate for a broad class of enzymes including sirtuins (SIRT1–7), PARPs (poly ADP-ribose polymerases), and CD38. NAD⁺ levels decline with age and in conditions of metabolic stress, linking it to aging biology, DNA repair capacity, mitochondrial function, and circadian rhythm regulation.\u003c\/p\u003e\u003cp\u003eIn research settings, NAD⁺ is studied as a substrate for sirtuin-mediated deacetylation reactions, a regulator of PARP-1-dependent DNA damage responses, and a mediator of calcium signalling via CD38\/cADPR pathways. Supplementation studies have investigated its role in restoring mitochondrial function, improving insulin sensitivity, and modulating the aging transcriptome in model organisms.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e 53-84-9  ·  \u003cstrong\u003eFormula:\u003c\/strong\u003e C21H27N7O14P2  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e 663.4 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥98%  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e Sirtuin substrate biology · PARP-1 \/ DNA repair · Mitochondrial bioenergetics · Aging \u0026amp; longevity research · Metabolic regulation · Circadian rhythm · CD38 signalling\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=NAD+nicotinamide+adenine+dinucleotide+sirtuin+aging+mitochondria\" target=\"_blank\" rel=\"noopener\"\u003ePubMed: NAD⁺ research literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"500mg","offer_id":53162478469453,"sku":null,"price":100.0,"currency_code":"GBP","in_stock":true},{"title":"1000mg","offer_id":53162478502221,"sku":null,"price":175.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/NAD_500mgBox-M.jpg?v=1770812090"},{"product_id":"slu-pp-332","title":"SLU-PP 332","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSLU-PP-332\u003c\/strong\u003e is a potent pan-agonist of the estrogen-related receptor (ERR) family — ERRα, ERRβ, and ERRγ — developed at St Louis University as a selective chemical probe for ERR-mediated transcriptional programmes. It functions as an exercise mimetic by activating the same mitochondrial biogenesis and oxidative metabolism pathways induced by physical exercise, without requiring physical activity.\u003c\/p\u003e\u003cp\u003eMechanistically, SLU-PP-332 drives ERR-dependent transcription of genes involved in fatty acid oxidation, OXPHOS complex assembly, and mitochondrial fusion dynamics. In rodent studies, it has been shown to increase aerobic exercise capacity and activate skeletal muscle fibre type switching. Its selectivity for ERRα\/β\/γ over classical oestrogen receptors (ERα\/β) makes it a valuable tool for dissecting ERR-specific biology.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003ePubChem CID:\u003c\/strong\u003e 5338394  ·  \u003cstrong\u003eFormula:\u003c\/strong\u003e C18H14N2O2  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e 294.3 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e ERRα\/β\/γ agonism · Mitochondrial biogenesis · Oxidative metabolism · Exercise mimetic pharmacology · Skeletal muscle biology · AMPK \/ OXPHOS signalling\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=SLU-PP-332+ERR+exercise+mimetic+mitochondria\" target=\"_blank\" rel=\"noopener\"\u003ePubMed: SLU-PP-332 research literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"5mg","offer_id":53425689198925,"sku":null,"price":45.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/SLU-PP3325mgBox-M.jpg?v=1770812052"},{"product_id":"adipotide","title":"Adipotide","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eAdipotide\u003c\/strong\u003e (CKGGRAKDC-GG-D(KLAKLAK)₂) is a chimeric pro-apoptotic peptide comprising two functional domains: a vascular-targeting domain (CKGGRAKDC) that binds to prohibitin-1 and annexin A2 on the surface of blood vessels feeding adipose tissue, and a cell-disrupting domain (D(KLAKLAK)₂) that induces mitochondrial apoptosis upon internalisation.\u003c\/p\u003e\u003cp\u003eOriginally developed for cancer vasculature targeting, Adipotide was repurposed as an adipose-selective pro-apoptotic agent. Preclinical studies in obese non-human primates demonstrated significant reduction in body mass and waist circumference through targeted elimination of fat-feeding vasculature, establishing it as a key research tool in adipose biology, angiogenesis targeting, and metabolic disease research.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003ePubChem CID:\u003c\/strong\u003e 163360068  ·  \u003cstrong\u003eFormula:\u003c\/strong\u003e C111H206N36O28S2  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e ~2,700 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e Adipose vascular targeting · Prohibitin \/ annexin A2 biology · Pro-apoptotic peptide design · Obesity \u0026amp; metabolic disease models · Angiogenesis research · Chimeric peptide pharmacology\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=adipotide+CKGGRAKDC+adipose+vascular+targeting+prohibitin\" target=\"_blank\" rel=\"noopener\"\u003ePubMed: Adipotide research literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"5mg","offer_id":53425623499085,"sku":null,"price":49.0,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/Adipotide-M.jpg?v=1772090778"},{"product_id":"epithalon","title":"Epithalon","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eEpithalon (Epitalon)\u003c\/strong\u003e (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide analogue of Epithalamin, a polypeptide extract of the pineal gland. Developed by Vladimir Khavinson and colleagues at the Saint Petersburg Institute of Bioregulation and Gerontology, Epithalon is studied for its role in telomerase activation, telomere elongation, and cellular aging regulation.\u003c\/p\u003e\u003cp\u003eFoundational research has demonstrated that Epithalon can induce expression of the catalytic subunit of telomerase (hTERT) in human somatic cells that normally lack this activity, resulting in measurable telomere elongation and extended cell division capacity beyond the Hayflick limit. Animal studies have reported significant life span extension in rodent models. This makes it one of the most studied synthetic tetrapeptides in longevity and cellular aging research.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e 307297-39-8  ·  \u003cstrong\u003eFormula:\u003c\/strong\u003e C14H22N4O9  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e 390.3 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e Telomerase activation · Telomere elongation · Cellular senescence · Pineal gland biology · Longevity research · Hayflick limit models\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSelected Research Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12937682\/\" target=\"_blank\" rel=\"noopener\"\u003eEpithalon induces telomerase activity and telomere elongation in human somatic cells (PMID 12937682)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15455129\/\" target=\"_blank\" rel=\"noopener\"\u003eEpithalon promotes overcoming the Hayflick division limit (PMID 15455129)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/14501183\/\" target=\"_blank\" rel=\"noopener\"\u003eEpitalon increases life span in SHR mice (PMID 14501183)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=epithalon+epitalon+telomerase+aging+telomere\" target=\"_blank\" rel=\"noopener\"\u003eFull PubMed literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"10mg","offer_id":53425648632141,"sku":null,"price":25.0,"currency_code":"GBP","in_stock":true},{"title":"50mg","offer_id":53425648664909,"sku":null,"price":65.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/Epithalon10mg-M.jpg?v=1772090686"},{"product_id":"ipamorelin","title":"Ipamorelin","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eIpamorelin\u003c\/strong\u003e (Aib-His-D-2-Nal-D-Phe-Lys-NH₂) is a synthetic pentapeptide and the first truly selective growth hormone secretagogue (GHS), developed as a tool to distinguish GHRP-mediated GH release from off-target ACTH, cortisol, and prolactin stimulation seen with earlier GHRPs such as GHRP-2 and GHRP-6. It acts as a potent, selective agonist at the ghrelin receptor (GHS-R1a).\u003c\/p\u003e\u003cp\u003eIpamorelin's exceptional GH-specificity makes it particularly valuable in research on the ghrelin\/GHS-R1a axis, pituitary somatotroph function, and GH\/IGF-1 pathway modulation without the confounding endocrine effects of less selective GHRPs. Pharmacokinetic studies in humans have characterised its dose-proportional GH stimulation profile, short half-life (~2 h), and clean endocrine selectivity profile.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e 170851-70-4  ·  \u003cstrong\u003eFormula:\u003c\/strong\u003e C38H49N9O5  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e 711.9 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e GHS-R1a \/ ghrelin receptor pharmacology · Selective GH secretagogue · Pituitary somatotroph biology · GH\/IGF-1 pathway · Endocrine selectivity studies · Metabolic research\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSelected Research Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9849822\/\" target=\"_blank\" rel=\"noopener\"\u003eIpamorelin: the first selective growth hormone secretagogue (PMID 9849822)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10496658\/\" target=\"_blank\" rel=\"noopener\"\u003ePK\/PD modelling of ipamorelin in human volunteers (PMID 10496658)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19289567\/\" target=\"_blank\" rel=\"noopener\"\u003eIpamorelin as a novel ghrelin mimetic (PMID 19289567)\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"Default Title","offer_id":53425666195789,"sku":null,"price":35.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/Ipamorelin5mg-M.jpg?v=1772090649"},{"product_id":"kiss-peptin-10","title":"Kisspeptin-10","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eKisspeptin-10\u003c\/strong\u003e (Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂) is the C-terminal decapeptide fragment of the kisspeptin family of neuropeptides, encoded by the KISS1 gene. It is the minimum active sequence required for full activation of GPR54 (KISS1R), the G-protein coupled receptor that serves as the principal regulator of gonadotropin-releasing hormone (GnRH) neuron activity.\u003c\/p\u003e\u003cp\u003eResearch has established kisspeptin-10 as a pivotal gatekeeper of the hypothalamic-pituitary-gonadal (HPG) axis, making it central to investigations of puberty onset, reproductive endocrinology, and fertility regulation. It is widely used in vitro and in vivo to probe GPR54 signalling, GnRH pulse generation, LH and FSH secretion, and the neuroendocrine control of reproduction. Kisspeptin-10 is also studied in the context of cancer biology due to KISS1's role as a metastasis suppressor.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e 374671-08-6  ·  \u003cstrong\u003eFormula:\u003c\/strong\u003e C63H83N15O13S  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e 1302.5 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e GPR54 \/ KISS1R pharmacology · GnRH regulation · HPG axis biology · Reproductive endocrinology · Puberty research · Metastasis suppression models\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=kisspeptin-10+GPR54+GnRH+reproductive+endocrinology\" target=\"_blank\" rel=\"noopener\"\u003ePubMed: Kisspeptin-10 research literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"5mg","offer_id":53425673306445,"sku":null,"price":25.0,"currency_code":"GBP","in_stock":true},{"title":"10mg","offer_id":53425673339213,"sku":null,"price":40.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/KissPeptin-1010mg-M.jpg?v=1772090621"},{"product_id":"l-carnitine","title":"L-Carnitine","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eL-Carnitine\u003c\/strong\u003e ((R)-3-carboxy-2-hydroxy-N,N,N-trimethylpropan-1-aminium) is a naturally occurring quaternary ammonium compound biosynthesised from lysine and methionine, found at high concentrations in cardiac and skeletal muscle. Its primary biochemical role is the transport of long-chain fatty acyl groups across the inner mitochondrial membrane via the carnitine shuttle system, enabling beta-oxidation and ATP production.\u003c\/p\u003e\u003cp\u003eIn laboratory research, L-Carnitine is studied as a cofactor in fatty acid oxidation assays, a modulator of the acyl-CoA\/CoA ratio, and an agent in mitochondrial energy metabolism studies. Research has also explored its role in oxidative stress reduction via removal of acyl groups that accumulate under metabolic stress conditions, and its potential in models of carnitine deficiency, insulin sensitivity, and exercise physiology.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e 541-15-1  ·  \u003cstrong\u003eFormula:\u003c\/strong\u003e C7H15NO3  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e 161.2 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99%  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Solution (500 mg\/10 mL)  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e 2–8 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e Mitochondrial fatty acid transport · Beta-oxidation · Carnitine shuttle system · Energy metabolism · Oxidative stress · Insulin sensitivity models\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=L-carnitine+mitochondria+fatty+acid+oxidation+metabolism\" target=\"_blank\" rel=\"noopener\"\u003ePubMed: L-Carnitine research literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"500mg\/10ml","offer_id":53425678385485,"sku":null,"price":25.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/L-Carnitine500mg10ml-M.jpg?v=1772090512"},{"product_id":"oxytocin","title":"Oxytocin","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eOxytocin\u003c\/strong\u003e (Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH₂; disulfide bridge Cys1–Cys6) is a nonapeptide hormone and neuropeptide produced in the paraventricular and supraoptic nuclei of the hypothalamus. It acts on OXTR (oxytocin receptor), a Gq-coupled GPCR expressed throughout the central and peripheral nervous systems, smooth muscle, and immune tissue.\u003c\/p\u003e\u003cp\u003eResearch applications for oxytocin span neuroscience, endocrinology, and behavioural biology. Key research areas include social bonding and pair bond formation, maternal behaviour, stress axis regulation via the HPA axis, anxiolytic mechanisms, trust and social cognition, and gut motility. Its well-characterised receptor pharmacology makes it a standard tool compound in GPCR research and behavioural neuroscience.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e 50-56-6  ·  \u003cstrong\u003eFormula:\u003c\/strong\u003e C43H66N12O12S2  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e 1007.2 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e OXTR receptor pharmacology · Social bonding \u0026amp; behaviour · HPA axis modulation · Maternal behaviour models · Anxiolytic mechanisms · Gut motility · Neuropeptide signalling\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=oxytocin+receptor+social+bonding+neuroendocrine+behaviour\" target=\"_blank\" rel=\"noopener\"\u003ePubMed: Oxytocin research literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"2mg","offer_id":53425681236301,"sku":null,"price":17.5,"currency_code":"GBP","in_stock":true},{"title":"10mg","offer_id":53425681269069,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/Oxytocin2mg-M.jpg?v=1772090457"},{"product_id":"snap-8","title":"Snap-8","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSnap-8 (Acetyl Octapeptide-3)\u003c\/strong\u003e is a synthetic eight-amino-acid acetylated peptide studied for its ability to inhibit SNARE complex formation at the neuromuscular junction. It mimics the N-terminal domain of SNAP-25, one of the three SNARE proteins required for synaptic vesicle fusion, thereby competitively reducing acetylcholine release and attenuating muscle contraction in research models.\u003c\/p\u003e\u003cp\u003eAs a longer-chain analogue of acetyl hexapeptide-3 (Argireline), Snap-8 is studied for its improved potency in SNARE inhibition assays and its application in cosmetic and dermatological research focused on dynamic expression line mechanisms. It is a standard reference compound in research on neuromuscular junction pharmacology, SNARE complex biology, and topical peptide delivery.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e 868844-74-0  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e ~1075 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e SNARE complex inhibition · Acetylcholine release modulation · Neuromuscular junction pharmacology · Cosmetic peptide research · SNAP-25 peptide biology · Topical delivery models\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=SNAP-8+SNARE+acetylcholine+acetyl+octapeptide+neuromuscular\" target=\"_blank\" rel=\"noopener\"\u003ePubMed: Snap-8 research literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"10mg \/ 1","offer_id":53425683890509,"sku":null,"price":22.5,"currency_code":"GBP","in_stock":true},{"title":"10mg \/ 5","offer_id":53898257170765,"sku":null,"price":100.0,"currency_code":"GBP","in_stock":true},{"title":"10mg \/ 10","offer_id":53898257203533,"sku":null,"price":175.0,"currency_code":"GBP","in_stock":true},{"title":"10mg \/ 15","offer_id":53898257236301,"sku":null,"price":225.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/Snap-810mg-M_e97db155-c4e0-4489-8501-648449b7654a.jpg?v=1772090418"},{"product_id":"pt-141","title":"PT-141","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003ePT-141 (Bremelanotide)\u003c\/strong\u003e is a synthetic cyclic heptapeptide melanocortin receptor agonist, structurally derived from Melanotan II via hydrolysis of the lactam bridge. Unlike PDE5 inhibitors, PT-141 acts centrally via melanocortin receptors (primarily MC3R and MC4R) in the hypothalamus and limbic system, making it a uniquely CNS-targeted research tool for studying sexual function and appetite signalling pathways.\u003c\/p\u003e\u003cp\u003ePT-141 has undergone extensive clinical investigation, culminating in FDA approval (as bremelanotide\/Vyleesi) for hypoactive sexual desire disorder in premenopausal women. This clinical history provides a substantial pharmacokinetic and safety dataset useful for research context. Preclinical research explores MC3R\/MC4R-mediated signalling, melanocortin CNS pathways, and peptide GPCR pharmacology.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e 189691-06-3  ·  \u003cstrong\u003eFormula:\u003c\/strong\u003e C50H68N14O10  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e 1025.2 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e MC3R \/ MC4R pharmacology · Melanocortin CNS pathways · Appetite \u0026amp; energy homeostasis · GPCR research · Reproductive endocrinology models\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=bremelanotide+PT-141+melanocortin+receptor+CNS\" target=\"_blank\" rel=\"noopener\"\u003ePubMed: PT-141 \/ Bremelanotide research literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"10mg","offer_id":53434496287053,"sku":null,"price":20.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/PT-141_10mg_Box-M.jpg?v=1772113460"},{"product_id":"mt2","title":"MT2","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eMT-2 (Melanotan II)\u003c\/strong\u003e is a synthetic cyclic lactam analogue of alpha-MSH, engineered for enhanced receptor binding affinity and metabolic stability versus the linear native peptide. It is a broadly promiscuous melanocortin receptor agonist, acting on MC1R, MC3R, MC4R, and MC5R — covering skin pigmentation, energy homeostasis, sexual function signalling, and exocrine gland biology respectively.\u003c\/p\u003e\u003cp\u003eMT-2 is one of the most studied melanocortin peptides in receptor pharmacology research. Its relative selectivity profiles across MCR subtypes, its cyclic lactam structure-activity relationships, and its downstream signalling via cAMP\/PKA pathways make it a versatile research tool for melanocortin system biology. It remains widely used in preclinical CNS, metabolic, and dermatological research.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e 121062-08-6  ·  \u003cstrong\u003eFormula:\u003c\/strong\u003e C50H69N15O9  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e 1024.2 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e MC1R \/ MC3R \/ MC4R \/ MC5R pharmacology · Melanogenesis · Energy homeostasis · Melanocortin CNS pathways · Structure-activity relationship (SAR) studies · cAMP \/ PKA signalling\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=melanotan+II+melanocortin+receptor+pigmentation+CNS\" target=\"_blank\" rel=\"noopener\"\u003ePubMed: Melanotan II research literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"1","offer_id":53898244751693,"sku":null,"price":25.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/MelanotanII10mg-M.jpg?v=1776331841"},{"product_id":"kpv","title":"KPV","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eKPV\u003c\/strong\u003e (Lys-Pro-Val; α-MSH residues 11–13) is the C-terminal tripeptide of alpha-melanocyte stimulating hormone (α-MSH). While short, KPV retains the principal anti-inflammatory bioactivity of the parent 13-residue peptide, acting primarily via MC1R-mediated pathways to suppress NF-κB activation and pro-inflammatory cytokine release (TNF-α, IL-1β, IL-6) in immune and epithelial cell models.\u003c\/p\u003e\u003cp\u003eResearch has demonstrated KPV's anti-inflammatory efficacy in models of colitis, skin inflammation, and wound healing. Its small molecular size, resistance to proteolysis (conferred by the C-terminal valine), and ability to modulate both innate immune and adaptive inflammatory responses make it a highly versatile research peptide. It has been explored for delivery via oral and topical routes in preclinical models.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eSequence:\u003c\/strong\u003e H-Lys-Pro-Val-OH (α-MSH 11–13)  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e 341.4 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e MC1R-mediated anti-inflammatory signalling · NF-κB suppression · Cytokine inhibition · Inflammatory bowel disease models · Wound healing · Skin inflammation\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=KPV+alpha-MSH+anti-inflammatory+melanocortin+tripeptide\" target=\"_blank\" rel=\"noopener\"\u003ePubMed: KPV research literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"10mg","offer_id":54279578976589,"sku":null,"price":37.5,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/kpv.png?v=1783835423"},{"product_id":"dermorphin","title":"DERMORPHIN","description":"\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 10% automatically. Add 3+ to save 15%. Applied at checkout.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eDermorphin\u003c\/strong\u003e (Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH₂) is a naturally occurring heptapeptide first isolated from the skin secretions of South American Phyllomedusa bicolor and Phyllomedusa sauvagei frogs. It was the first naturally occurring opioid peptide found to contain a D-amino acid residue (D-alanine at position 2), which confers exceptional μ-opioid receptor (MOR) selectivity and metabolic stability versus endogenous enkephalins and endorphins.\u003c\/p\u003e\u003cp\u003eDermorphin is among the most potent natural μ-opioid receptor agonists known, with binding affinity and potency several hundred times greater than morphine. In research, it is used as a selective μ-opioid receptor probe to study MOR pharmacology, opioid receptor structure-activity relationships, pain signalling pathways, and the role of D-amino acid incorporation in peptide biology.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e 77614-16-5  ·  \u003cstrong\u003eFormula:\u003c\/strong\u003e C40H54N8O11S  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e 882.97 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e μ-opioid receptor (MOR) pharmacology · Opioid receptor SAR · D-amino acid peptide biology · Pain signalling models · Endogenous opioid systems · Amphibian peptide chemistry\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=dermorphin+opioid+receptor+peptide+D-amino+acid\" target=\"_blank\" rel=\"noopener\"\u003ePubMed: Dermorphin research literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"Default Title","offer_id":54279618199885,"sku":null,"price":69.0,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/DERMORPHIN.png?v=1783835925"}],"url":"https:\/\/www.peptide-biosciences.com\/collections\/all-research-peptides.oembed","provider":"Peptide Biosciences","version":"1.0","type":"link"}